Start with what life feels like now

What can electrical and magnetic therapies add to a plan?

We help people with pain that limits sitting, walking or sleeping by examining movement and nervous-system factors so that they can work toward the activities pain has interrupted.

How we look at the whole picture

You plan your day around how long you can sit, stand or walk before pain takes over.

You have tried to keep going, but a sore neck, back or joint keeps bringing you back to the same limits.

You do not need to know which treatment to ask for. Start with what has changed and what you want to be able to do again.

The 7 Domains of Recovery™

Your symptoms may belong in the same conversation.

Pain can involve tissue, movement, nerve sensitivity, sleep and stress. The seven-domain approach considers how these factors may be sustaining the problem.

Neuregen's proprietary 7 Domains of Recovery framework organizes that conversation around seven connected parts of your life and health. We consider all seven, then focus the evaluation on the questions your history raises.

Explore our clinical framework

1Brain function & neural networks
What has changed in your memory, concentration, balance or sensory tolerance?
2Autonomic & nervous system regulation
What happens when you stand, move, rest or encounter stress?
3Immune function & neuroinflammation
What immune history, reactions or symptoms need a closer look?
4Brain energy & metabolic health
What affects your energy through the day and after activity?
5Structure, stability & body-to-brain signals
How do pain, posture, movement and stability affect what you can do?
6Psychological flexibility & behavioral recovery
How are mood, stress and patterns of coping affecting your day?
7Life, relationships & environment
What demands, relationships and support shape your recovery?

A plan starts with the things you want to do again.

We review the pattern of pain, the examination and any relevant prior imaging. We agree on a functional goal, such as sitting through a meal or walking farther, before choosing care.

01
Tell us what you want your life to look like
We start with what has changed, what you have tried, and the activities you most want to return to.
02
Answer the questions the history leaves open
We review prior reports and select relevant assessments. You should understand what each assessment is meant to clarify.
03
Agree on the priorities and the first steps
We discuss the findings, possible approaches, costs and practical constraints. The plan sets an order that fits your situation.
04
Check what changes and adjust together
We compare your response with the starting point, including daily function. If something is not helping, we discuss what needs to change.

Only then do we discuss which therapies, if any, belong in your plan. The choice depends on the findings, the evidence, your preferences and how you respond.

Talk through your situation

Regenerative Therapies · PEMF & Electric Modalities

PEMF & Electric Modalities

Pulsed electromagnetic fields and electrical stimulation used to reduce pain and support tissue and nerve-muscle recovery inside your plan.

Book a Strategy Consultation How we build your plan

Conceptual artwork for the care discussion. Individual findings and treatment options require clinical evaluation.

How these modalities work

A pulsed electromagnetic field (PEMF) device generates a time-varying magnetic field that induces small electrical currents in the tissue beneath it. Proposed effects include changes in ion-channel activity and calcium signaling, shifts in inflammatory mediators, and improved microcirculation. The clinical footing is strongest for bone: PEMF devices are FDA-cleared for non-union fractures and certain post-operative fusion settings. Studies in musculoskeletal pain are mixed, and neurologic applications are at an earlier stage.

Electrical modalities are older and more familiar. Transcutaneous electrical nerve stimulation (TENS) applies current through skin electrodes to modulate pain signaling at the spinal cord. Neuromuscular electrical stimulation (NMES) drives muscle contraction directly and is used to re-activate muscle after deconditioning or neurologic injury. Both have a long history in physical medicine; the evidence for lasting benefit in chronic pain is mixed, and the effect is usually strongest during and shortly after use.

Neuregen uses these tools for what they do reliably: lower pain and muscle guarding enough for rehabilitation to proceed, and support tissue recovery around regenerative injections. We set the parameters and screen for contraindications, including implanted electronic devices, pregnancy, and some seizure histories. If a modality is not moving a domain, it is stopped.

Domains most involved:

Every plan starts from the same map: the 7 Domains of Recovery.

How it fits your plan

Electrical or electromagnetic options may be considered alongside rehabilitation. We discuss the reason for using them and review whether they are contributing to the goals you agreed on.

Interest in a regenerative therapy is a reason to ask questions, not evidence that it fits your condition. We connect any proposed option to the evaluation, review established alternatives and distinguish research mechanisms from demonstrated clinical benefit.

We review your history, explain the findings, agree on next steps and check how you respond.

Potential Therapies

We use established medicine where it works, and emerging medicine where it makes sense.

These are options to discuss after evaluation, not a predetermined treatment plan. Each label refers to the condition or indication described beside that therapy; evidence can differ for another use. An evidence label does not mean FDA approval.

Before considering experimental therapies

Stem-cell and exosome treatments discussed here for brain and nervous-system recovery are experimental, not FDA-approved treatments for these conditions. Potential benefits remain uncertain, and serious harms can occur. Their inclusion here does not establish availability or eligibility.

Peptide protocols discussed for neural repair are investigational. Compounded drugs are not FDA approved; FDA does not review their safety, effectiveness or quality before marketing. Approval and lawful use depend on the specific product and indication. Informed consent alone does not establish regulatory authorization.

We discuss the evidence, product-specific risks, alternatives and regulatory status before any treatment decision. PRP and other biologics also need a separate review for the proposed use.

FDA: regenerative medicine information FDA: compounded medicines

Pulsed electromagnetic field (PEMF) therapyEvidence: Emerging
FDA-cleared for bone healing; musculoskeletal pain and neurologic uses are emerging
TENS (transcutaneous electrical nerve stimulation)Evidence: Emerging
Pain modulation through surface electrodes; long-used in physical medicine, lasting benefit in chronic pain is mixed
NMES (neuromuscular electrical stimulation)Evidence: Emerging
Muscle re-activation after deconditioning or neurologic injury; used to enable rehabilitation work

Where the evidence stands

PEMF has established, FDA-cleared uses in bone healing. For pain and neurologic recovery, PEMF and electrical stimulation carry emerging evidence with mixed trial results. Neuregen uses them as adjuncts and does not claim outcomes beyond symptom relief that enables rehabilitation.

Sources and what they support

FDA information about regenerative medicine therapies
Regulatory and safety information about unapproved regenerative products. This is a disclosure source, not evidence that a product benefits a particular condition.

How we grade evidence

How we label evidence

Each grade describes the evidence for a particular treatment and use. It does not guarantee an outcome or establish regulatory approval.

Level 1
Evidence: Strong
Multiple high-quality studies consistently support meaningful benefit for this use. Results are unlikely to change substantially with additional research.
Level 2
Evidence: Moderate
Good clinical evidence supports benefit, but important uncertainty remains about magnitude, patient selection, long-term outcomes, or generalizability.
Level 3
Evidence: Emerging
Early clinical studies suggest potential benefit, but the evidence is not yet strong or consistent enough for confident conclusions.
Level 4
Evidence: Preliminary
Evidence is limited to small studies, case series, retrospective data, or indirect clinical evidence. Benefit remains uncertain.
Level 5
Evidence: Investigational
There is biological rationale or very early clinical evidence, but efficacy for this use has not been established.

Some care pages also use Established to describe an established clinical use. That label is not an automatic Level 1 or Level 2 rating; the strength of evidence must be reviewed for the specific indication.

Promising does not mean proven. Your clinician considers the indication, alternatives, risks and your circumstances before recommending care.

Pricing

Service	Price
Strategy ConsultationA real clinical conversation, not a sales call	Confirmed in writing at your Strategy Consultation

Neuregen is an out-of-network specialty clinic. Most therapies listed here are not covered by insurance; we provide itemized documentation you can submit to your insurer, and we tell you before any therapy which parts, if any, are typically reimbursed.

Financing options are reviewed at your Strategy Consultation before any plan is finalized.

The training behind this care

Neuregen considers regenerative options within a rehabilitation plan, with condition-specific evidence labels and upfront discussion of experimental status. The purpose is to decide whether an option belongs in your care at all.

Dr. David George: Board certifications and training in functional neurology, integrative psychiatry, and mental health; certified brain injury specialist.

Training most relevant to this area

NASM Certified Corrective Exercise Specialist
Ultrasound-guided neural hydrodissection and neural prolotherapy (perineural injection therapy)
Ultrasound-guided joint injections and nerve blocks
Regenerative/cellular medicine (PRP, stem cell, exosome therapies)

These are the founder’s qualifications. We confirm the treating clinician and their role when discussing your plan.

See Dr. George’s full credentials

modality

condition

domain

Frequently asked questions

Is PEMF the same as a magnetic bracelet or mattress pad?

No. Static magnets in bracelets and pads do not produce a time-varying field and have no demonstrated therapeutic effect. PEMF devices pulse the field at set frequencies and intensities, which is what induces current in tissue. Consumer PEMF mats also exist; their parameters vary and they are not what is used here.

What does a session feel like?

PEMF is usually not felt at all, or as a mild pulsing sensation. TENS produces a tingling under the electrodes. NMES produces visible muscle contraction, which can feel unusual at first but should not be painful. Intensity is adjusted to your tolerance.

Who should not receive these modalities?

People with pacemakers, implanted defibrillators, or other implanted electronic devices, anyone who is pregnant, and some people with seizure disorders are screened out or treated only with specific precautions. We review your history before any modality is added.

Do these replace injections or rehabilitation?

No. They are used to lower pain and muscle guarding so that rehabilitation and, where indicated, regenerative injections can do their work. If a modality is not contributing to progress, it is removed from the plan.

Start with a Strategy Consultation

Persistent pain or reduced function may already be changing how you spend your days. A consultation can help you compare options and unanswered questions; there is no deadline to choose an experimental treatment.

Book a Strategy Consultation 866-999-1177

8090 N. 85th Way, Suite 100, Scottsdale, AZ 85258 · Mon–Thu, 9:00 AM – 5:30 PM